Menu
Back to Journals » OncoTargets and Therapy » Volume 16
Original Research
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,650 | Dovepress* | 3,264+ | 76 | 3,340 | |
| PubMed Central* | 386 | 64 | 450 | ||
| Totals | 3,650 | 140 | 3,790 | ||
| *Since 1 April 2023 | |||||
View citations on PubMed Central and Google Scholar